167 related articles for article (PubMed ID: 11062508)
21. [HIV genetic diversity and its consequences].
Roquebert B; Damond F; Brun-Vézinet F; Descamps D
Pathol Biol (Paris); 2009 Mar; 57(2):142-8. PubMed ID: 18511216
[TBL] [Abstract][Full Text] [Related]
22. HIV/AIDS research after HAART.
Gallo RC
Res Initiat Treat Action; 2005; 11(1):39-41. PubMed ID: 16208818
[No Abstract] [Full Text] [Related]
23. HIV-1 care in resource-poor settings: a view from Haiti.
Mukherjee JS
Lancet; 2003 Sep; 362(9388):994-5. PubMed ID: 14513853
[No Abstract] [Full Text] [Related]
24. Remune trial ended.
Res Initiat Treat Action; 1999 Jul; 5(3):28. PubMed ID: 11366725
[TBL] [Abstract][Full Text] [Related]
25. [HIV infection has become treatable: a medical success that helps only a few].
MMW Fortschr Med; 2006 Oct; 148(42):19. PubMed ID: 17621793
[No Abstract] [Full Text] [Related]
26. Provision of treatment in HIV-1 vaccine trials in developing countries.
Fitzgerald DW; Pape JW; Wasserheit JN; Counts GW; Counts GW; Corey L
Lancet; 2003 Sep; 362(9388):993-4. PubMed ID: 14513852
[No Abstract] [Full Text] [Related]
27. AIDS medicines in development.
Pediatr AIDS HIV Infect; 1996 Apr; 7(2):122-31. PubMed ID: 11361481
[No Abstract] [Full Text] [Related]
28. Cold shower for AIDS vaccines.
Nat Med; 2007 Dec; 13(12):1389-90. PubMed ID: 18064013
[No Abstract] [Full Text] [Related]
29. Antiretroviral therapy and resistance to antiretroviral drugs.
Lange JM; van Leeuwen R
Ethiop Med J; 2002 Apr; 40 Suppl 1():51-75. PubMed ID: 12802831
[TBL] [Abstract][Full Text] [Related]
30. [New possibilities of the drug therapy of HIV infection].
Ristola M; Järvinen A
Duodecim; 1999; 115(20):2249-57. PubMed ID: 11973929
[No Abstract] [Full Text] [Related]
31. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
Krogstad PA
J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
[No Abstract] [Full Text] [Related]
32. Start anti-HIV treatment early, in adults and infants.
Laurence J
AIDS Read; 2009 Jan; 19(1):6-7, 17. PubMed ID: 19209449
[No Abstract] [Full Text] [Related]
33. Therapeutic vaccination for HIV disease.
Laurence J; Johnston R
AIDS Read; 2003 Jun; 13(6):252-3, 260. PubMed ID: 12846168
[No Abstract] [Full Text] [Related]
34. A selection of trends in HIV research.
Bean P
Am Clin Lab; 2001 Jul; 20(6):12-4. PubMed ID: 11480386
[No Abstract] [Full Text] [Related]
35. HIV viremia and the development of AIDS-related lymphoma in patients treated with highly active antiretroviral therapy.
Sabin CA
J Infect Dis; 2009 Jul; 200(1):8-10. PubMed ID: 19476436
[No Abstract] [Full Text] [Related]
36. Questions, questions. The future of HIV research.
Huff B
GMHC Treat Issues; 2005 Dec; 19(12):4-8. PubMed ID: 16909507
[No Abstract] [Full Text] [Related]
37. Honing the test-and-treat HIV strategy.
Mastro TD; Cohen MS
Science; 2010 May; 328(5981):976. PubMed ID: 20489007
[No Abstract] [Full Text] [Related]
38. New medicines in development for AIDS: 1995 survey from the Pharmaceutical Research and Manufacturers of America.
Pediatr AIDS HIV Infect; 1996 Apr; 7(2):120-1. PubMed ID: 11361480
[No Abstract] [Full Text] [Related]
39. We've entered the fourth decade in the battle against HIV/AIDS.
Kresge KJ
IAVI Rep; 2010; 14(1):2. PubMed ID: 20349581
[No Abstract] [Full Text] [Related]
40. Bridging the gap?
del Rio C; Soto-Ramirez LE
AIDS Clin Care; 1998 Sep; 10(9):65-7, 69, 72. PubMed ID: 11365808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
